Physician profile
Barbara Webster
NPI 1649232323
$3,282.26
in general payments reported to CMS, 2019-2025
33 companies · $334 in 2025
The $334 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2020: $164 · 2021: $367 · 2022: $388 · 2023: $937 · 2024: $777 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,048.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,048.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $376.61 | 2024-2025 | Zurzuvae, Vumerity |
| Shield Therapeutics INC | $356.89 | 2023-2025 | Accrufer |
| Abbvie INC. | $282.95 | 2019-2023 | Lo Loestrin Fe |
| Exeltis, USA INC. | $257.01 | 2019-2024 | Slynd |
| Organon LLC | $173.21 | 2021-2025 | Nexplanon |
| Astellas Pharma US INC | $159.97 | 2023-2024 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $157.35 | 2021-2025 | |
| Aspira Women'S Health INC | $134.60 | 2021-2023 | Ova1 |
| Hologic Sales and Service, LLC | $125.17 | 2019-2025 | Novasure |
| Ethicon US, LLC | $122.64 | 2021-2023 | Vistaseal, Enseal, Dermabond Prineo |
| Agile Therapeutics, INC. | $118.94 | 2021-2024 | Twirla |
| Sumitomo Pharma America, INC. | $114.35 | 2023-2024 | Myfembree |
| Therapeuticsmd, INC. | $112.84 | 2019-2020 | |
| Evofem Biosciences, INC. | $102.74 | 2021-2025 | Solosec, Phexx, Phexxi |
| Myriad Women'S Health, INC. | $97.40 | 2023 | Myrisk |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $96.04 | 2022-2023 | Injectafer |
| Minerva Surgical, INC | $92.46 | 2023 | |
| Pfizer INC. | $59.52 | 2023-2024 | |
| Lupin INC. | $48.98 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $30.09 | 2019-2020 | |
| Innovation Technologies INC | $29.00 | 2023 | Irrisept |
| Merck Sharp & Dohme LLC | $26.36 | 2020-2021 | |
| Myovant Sciences INC. | $24.29 | 2021 | |
| Medtronic, INC. | $24.18 | 2023 | V-Loc 180 |
| Pacira Pharmaceuticals Incorporated | $22.76 | 2023 | Iovera, Zilretta, Exparel |
| Allergan, INC. | $22.44 | 2019-2020 | |
| Meditrina | $19.75 | 2023 | |
| Novo Nordisk INC | $18.80 | 2022 | |
| Mycovia Pharmaceuticals, INC. | $18.14 | 2023 | Vivjoa |
| Coopersurgical, INC. | $15.82 | 2022 | |
| Avion Pharmaceuticals | $14.98 | 2019 | |
| Novum Pharma, LLC | $14.26 | 2019 | |
| Amag Pharmaceuticals, INC. | $11.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Webster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.